Total Funding
40
44
Total FundingSeries B raised
Growth Score
-41 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
39291
Eccogene discovers and develops translational medicine in metabolic and immune-related diseases.
- Jingye Zhou: Co-founder and CEO
- Jianfeng Xu: Co-Founder and CSO
About the Company
Eccogene is a clinical stage biopharmaceutical company that provides therapeutic solutions to address unmet medical needs. They offer services in the discovery and development of translational medicine in metabolic and immune-related diseases.
